首页> 美国卫生研究院文献>Current Urology >Robotic Partial Cystectomy for Primary Urachal Adenocarcinoma of the Urinary Bladder
【2h】

Robotic Partial Cystectomy for Primary Urachal Adenocarcinoma of the Urinary Bladder

机译:机器人部分膀胱切除术治疗原发性膀胱尿道腺癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We present the largest reported consecutive series on robotic partial cystectomy in the management of patients with primary urachal adenocarcinoma. Eight patients with primary urachal adenocarcinoma of the urinary bladder underwent a robotic partial cystectomy. The mean operative time, including trocar placement as well as robotic docking and closure was 184 minutes (range 130–240 minutes). The mean console time was 120 minutes (range 70–170 minutes). The mean estimated blood loss was 50 ml. There were no conversions to open surgery. The mean hospital stay was 4 days (range 3–7 days). Drain removal was performed at postoperative day 2.5 (range 2–3 days). Each patient underwent postoperative cystography on day 10 postoperatively and no patients had evidence of extravasation. There were no major complications. Histological analysis of all tumors confirmed primary urachal adenocarcinoma of the urinary bladder. There were no positive surgical margins. At a mean follow up of 32 months none of the patients have had a disease recurrence with any evidence of disease recurrence. Our initial data indicates that with robotic partial cystectomy for primary urachal adenocarcinoma of the urinary bladder is a safe surgical and oncological procedure. However, longer follow up and larger patient numbers are required to validate this further.
机译:我们提出了最大的连续系列机器人部分膀胱切除术治疗原发性尿道腺癌患者的研究。八名原发性膀胱尿道腺癌患者接受了机器人部分膀胱切除术。平均手术时间为184分钟(范围为130–240分钟),包括套管针放置以及机器人对接和闭合。平均控制台时间为120分钟(范围为70-170分钟)。平均估计失血量为50毫升。没有转换为开放手术。平均住院时间为4天(3-7天)。术后第2.5天(2-3天)进行了引流。每例患者在术后第10天接受了膀胱镜检查,没有患者有渗出的迹象。没有重大并发症。所有肿瘤的组织学分析证实了原发性膀胱尿道腺癌。没有积极的手术切缘。平均随访32个月,所有患者均未出现疾病复发,也没有任何疾病复发的迹象。我们的初步数据表明,使用机器人部分膀胱切除术治疗原发性膀胱尿道腺癌是安全的外科手术和肿瘤学手术。但是,需要更长的随访时间和更大的患者人数才能进一步验证这一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号